Maynard Um
-
-
-
-
-
-
-
Zenas Biopharma (ZBIO) PT Lowered to $48 at Jefferies, 'we see clear path for approval (BLA submission planned in 2Q and MAA in 2H26')
-
-
-
-
-
-
-
Zenas Biopharma (ZBIO) PT Raised to $44 at H.C. Wainwright
-
-
-
-
-
-
-
Morgan Stanley Assumes Zenas Biopharma (ZBIO) at Overweight
-
-
-
-
-
-
-
INVESTOR DEADLINE NEXT WEEK: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - ZBIO
-
-
-
-
-
-
-
ZBIO DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities
-
-
-
-
-
-
-
ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
-
-
-
-
-
-
-
ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
-
404,946 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

